Apr 29, 2024 07:04AM
Apr 29, 2024 07:00AM
Apr 17, 2023 07:00AM
Mar 20, 2023 08:00AM
Mar 13, 2023 08:00AM
Feb 6, 2023 08:00AM
Jan 25, 2023 08:00AM Oncotelic Initiates Clinical Trials Evaluating OT-101 against Metastatic Pancreatic Cancer
Jan 17, 2023 08:00AM
Dec 28, 2022 08:02AM
Dec 28, 2022 08:00AM
Dec 19, 2022 08:00AM
Nov 30, 2022 08:00AM
Nov 21, 2022 09:00AM
Nov 16, 2022 08:00AM Oncotelic Publishes SITC Meeting 2022 Presentation Materials
Nov 8, 2022 07:33AM
Sep 28, 2022 08:55AM
Sep 14, 2022 08:15AM
Aug 22, 2022 09:00AM
Aug 17, 2022 08:00AM
Jul 12, 2022 07:00AM
Jun 15, 2022 07:00AM Oncotelic Provides Update on OT-101 at the 2022 BIO International Convention
May 25, 2022 07:00AM
May 23, 2022 11:14AM
May 18, 2022 08:00AM
May 11, 2022 07:00AM
May 4, 2022 07:03AM
May 4, 2022 07:00AM
May 3, 2022 07:00AM Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as Chief Medical Officer
Apr 18, 2022 07:00AM
Apr 7, 2022 10:00AM
Apr 4, 2022 07:00AM
Mar 10, 2022 08:05AM
Mar 3, 2022 08:01AM
Feb 24, 2022 08:47AM
Feb 24, 2022 08:01AM Oncotelic Presenting at BiotechGate Digital Partnering
Jan 19, 2022 09:05AM
Jan 5, 2022 08:01AM
Dec 1, 2021 09:01AM
Nov 23, 2021 07:30AM
Nov 16, 2021 08:15AM
Oct 4, 2021 07:00AM
Sep 1, 2021 12:00PM ONCOTELIC TO ACQUIRE LATE-STAGE DRUG CANDIDATE FOR PARKINSON DISEASE, ERECTILE DYSFUNCTION, AND FEMALE SEXUAL DYSFUNCTION.
Apr 19, 2021 12:00PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All